Abstract
The present study aimed to assess anti-inflammatory activity and underlying mechanism of n-propyl gallate, the n-propyl ester of gallic acid. n-Propyl gallate was shown to contain anti-inflammatory activity using two experimental animal models, acetic acid-induced permeability model in mice, and air pouch model in rats. It suppressed production of nitric oxide and induction of inducible nitric oxide synthase and cyclooxygenase-2 in the lipopolysaccharide (LPS)-stimulated RAW264.7 macrophage cells. It was able to diminish reactive oxygen species level elevated in the LPS-stimulated RAW264.7 macrophage cells. It also suppressed gelatinolytic activity of matrix metalloproteinase-9 enhanced in the LPS-stimulated RAW264.7 macrophage cells. It inhibited inhibitory κB-α degradation and enhanced NF-κB promoter activity in the stimulated macrophage cells. It was able to suppress phosphorylation of c-Jun NH2-terminal kinase 1/2 (JNK1/2) and activation of c-Jun promoter activity in the stimulated macrophage cells. In brief, n-propyl gallate possesses anti-inflammatory activity via down-regulation of NF-κB and JNK pathways.
Similar content being viewed by others
Abbreviations
- COX-2:
-
Cyclooxygenase-2
- DCFH-DA:
-
2′,7′-dichlorofluorescein diacetate
- DMEM:
-
Dulbecco's modified Eagle's medium
- IC50 :
-
Half maximal inhibitory concentration
- LPS:
-
Lipopolysaccharide
- MAPK:
-
Mitogen-activated protein kinase
- MMP:
-
Matrix metalloproteinase
- MTT:
-
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
- NO:
-
Nitric oxide
- ROS:
-
Reactive oxygen species
References
Reddan, J.R., F.J. Giblin, M. Sevilla, V. Padgaonkar, D.C. Dziedzic, V.R. Leverenz, I.C. Misra, J.S. Chang, and J.T. Pena. 2003. Propyl gallate is a superoxide dismutase mimic and protects cultured lens epithelial cells from H2O2 insult. Experimental Eye Research 76: 49–59.
Chen, C.H., T.Z. Liu, C.H. Chen, C.H. Wong, C.H. Chen, F.J. Lu, and S.C. Chen. 2007. The efficacy of protective effects of tannic acid, gallic acid, ellagic acid, and propyl gallate against hydrogen peroxide-induced oxidative stress and DNA damages in IMR-90 cells. Molecular Nutrition & Food Research 51: 962–968.
Karthikeyan, K., B.R. Sarala Bai, K. Gauthaman, and S. Niranjali Devaraj. 2005. Protective effect of propyl gallate against myocardial oxidative stress-induced injury in rat. The Journal of Pharmacy and Pharmacology 57: 67–73.
Jacobi, H., M.-L. Hinrichsen, D. Wess, and I. Witte. 1999. Induction of lipid peroxidation in human fibroblasts by the antioxidant propyl gallate in combination with copper (II). Toxicology Letters 110: 183–190.
Golden, A., J.S. Brugge, and S.J. Shattil. 1990. Role of platelet membrane glycoprotein IIb/IIIa in agonist-induced tyrosine phosphorylation of platelet proteins. The Journal of Cell Biology 111: 3117–3127.
Speck, R. 1994. Comparison of slide platelet aggregation reagents. American Clinical Laboratory 13: 22–23.
Xiao, H., R. Kovics, V. Jackson, and D.G. Remick. 2004. Effects of platelet inhibitors on propyl gallate-induced platelet aggregation, protein tyrosine phosphorylation, and platelet factor 3 activation. Blood Coagul Fibrinol 15: 199–206.
Tsukiyama, F., Y. Nakai, M. Yoshida, T. Tokuhara, K. Hirota, A. Sakai, H. Hayashi, and T. Katsumata. 2006. Gallate, the component of HIF-inducing catechins, inhibits HIF prolyl hydroxylase. Biochemical and Biophysical Research Communications 351: 234–239.
Ter Veld, M.G., B. Schouten, J. Louisse, D.S. Van Es, P.T. Van Der Saag, I.M. Rietjens, and A.J. Murk. 2006. Estrogenic potency of food-packaging-associated plasticizers and antioxidants as detected in ERα and ERβ reporter gene cell lines. J Agri Food Chem 54: 4407–4416.
McDonald-Gibson, W.J., S.A. Saeed, and C. Schneider. 1976. The local anti-nociceptive and topical anti-inflammatory effects of propyl gallate in rodents. British Journal of Pharmacology 58: 573–581.
Whittle, B.A. 1964. The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics. Br J Pharmacol Chemother 22: 246–253.
Ghosh, A.K., N. Hirasawa, H. Niki, and K. Ohuchi. 2000. Cyclooxygenase-2-mediated angiogenesis in carrageenan-induced granulation tissue in rats. The Journal of Pharmacology and Experimental Therapeutics 295: 802–809.
Sherman, M.P., E.E. Aeberhard, V.Z. Wong, J.M. Griscavage, and L.J. Ignarro. 1993. Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochemical and Biophysical Research Communications 191: 1301–1308.
Kleiner, D.E., and W.G. Stetler-Stevenson. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Analytical Biochemistry 218: 325–329.
Royall, J.A., and H. Ischiropoulos. 1993. Evaluation of 2′, 7′-dichlorofluorescin and dihydrorhodamine 123 as fluorescent probes for intracellular H2O2 in cultured endothelial cells. Archives of Biochemistry and Biophysics 302: 348–355.
Freshney, R.I. 1994. Culture of animal cells: a manual of basic technique, 4th ed, 336–338. New York: Wiley-Liss Press.
Alamed, J., W. Chaiyasit, D.J. McClements, and E.A. Decker. 2009. Relationship between free radical scavenging and antioxidant activity in foods. J Agri Food Chem 57: 2969–2976.
Lowenstein, C.J., E.W. Alley, P. Raval, A.M. Snowman, S.H. Snyder, S.W. Russell, and W.J. Murphy. 1993. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America 90: 9730–9734.
Baldwin, A.S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annual Review of Immunology 14: 649–681.
Vogel, H.G., and W.H. Vogel. 1997. Drug discovery and evaluations, pharmacological assays, 402–403. Berlin: Springer.
Singh, V.K., S. Mehrotra, P. Narayan, C.M. Pandey, and S.S. Agarwal. 2000. Modulation of autoimmune diseases by nitric oxide. Immunologic Research 22: 1–19.
Cuzzocrea, S. 2006. Role of nitric oxide and reactive oxygen species in arthritis. Current Pharmaceutical Design 12: 3551–3570.
Chesrown, S.E., J. Monnier, G. Visner, and H.S. Nick. 1994. Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochemical and Biophysical Research Communications 200: 126–134.
Nordberg, J., and E.S. Arner. 2001. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system. Free Radical Biology & Medicine 31: 1287–1312.
Bubici, C., S. Papa, K. Dean, and G. Franzoso. 2006. Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25: 6731–6748.
Mott, J.D., and Z. Werb. 2004. Regulation of matrix biology by matrix metalloproteinases. Current Opinion in Cell Biology 16: 558–564.
Sorsa, T., L. Tjäderhane, Y.T. Konttinen, A. Lauhio, T. Salo, H.-M. Lee, L.M. Golub, D.L. Brown, and P. Mäntylä. 2006. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Annali Medici 38: 306–321.
Annabi, B., J.C. Currie, A. Moghrabi, and R. Béliveau. 2007. Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg. Leukemia Research 31: 1277–1284.
Hsiang, C.-Y., S.-L. Wu, J.-C. Chen, H.-Y. Lo, C.-C. Li, S.-Y. Chiang, H.-C. Wu, and T.-Y. Ho. 2007. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-κB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: association with the invasive potential. Toxicology Letters 171: 78–86.
Jachak, S.M. 2006. Cyclooxygenase inhibitory natural products: current status. Current Medicinal Chemistry 13: 659–678.
Mandrekar, P., D. Catalano, and G. Szabo. 1999. Inhibition of lipopolysaccharide-mediated NF-κB activation by ethanol in human monocytes. International Immunology 11: 1781–1790.
Ajizian, S.J., B.K. English, and E.A. Meals. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. The Journal of Infectious Diseases 179: 939–944.
Raingeaud, J., S. Gupta, J.S. Rogers, M. Dickens, J. Han, R.J. Ulevitch, and R.J. Davis. 1995. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine. The Journal of Biological Chemistry 270: 7420–7426.
Minden, A., and M. Karin. 1997. Regulation and function of the JNK subgroup of MAP kinases. Biochimica et Biophysica Acta 1333: F85–F104.
Wang, X., J.L. Martindale, and N.J. Holbrook. 2000. Requirement for ERK activation in cisplatin-induced apoptosis. The Journal of Biological Chemistry 275: 39435–39443.
Communal, C., W. Colucci, and K. Singh. 2000. p38 mitogen-activated protein kinase pathway protects adult rat ventricular myocytes against beta-adrenergic receptor-stimulated apoptosis. Evidence for Gi-dependent activation. The Journal of Biological Chemistry 275: 19395–19400.
Liu, B., M. Fang, Y. Lu, Y. Lu, G.B. Mills, and Z. Fan. 2001. Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells. British Journal of Cancer 85: 303–311.
Kim, S.-J., H.-J. Jeong, K.-M. Lee, N.-Y. Myung, N.-H. An, W.M. Yang, S.K. Park, H.-J. Lee, S.-H. Hong, H.-M. Kim, and J.-Y. Um. 2007. Epigallocatechin-3-gallate suppresses NF-κB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. The Journal of Nutritional Biochemistry 18: 587–596.
Hou, D.-X., S. Masuzaki, F. Hashimoto, T. Uto, S. Tanigawa, M. Fujii, and Y. Sakata. 2007. Green tea proanthocyanidins inhibit cyclooxygenase-2 expression in LPS-activated macrophages: molecular mechanisms and structure–activity relationship. Archives of Biochemistry and Biophysics 460: 67–74.
Hou, D.-X., D. Luo, S. Tanigawa, F. Hashimoto, T. Uto, S. Masuzaki, M. Fujii, and Y. Sakata. 2007. Prodelphinin B-4 3′-O-gallate, a tea polyphenol, is involved in the inhibition of COX-2 and iNOS via the downregulation of TAK1-NF-κB pathway. Biochemical Pharmacology 74: 742–751.
Acknowledgments
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0072536). We wish to acknowledge Ms. Hyun-Jung Kang for her technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jung, HJ., Kim, SJ., Jeon, WK. et al. Anti-inflammatory Activity of n-Propyl Gallate Through Down-regulation of NF-κB and JNK Pathways. Inflammation 34, 352–361 (2011). https://doi.org/10.1007/s10753-010-9241-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-010-9241-0